Aareen Healthcare
Incorporated in 2007 and headquartered in India, the company markets a broad portfolio of pharmaceutical formulations across acute and chronic therapeutic areas. It reports business over 100 crore INR, a workforce of 300+ staff, distribution across 13 Indian states/UTs, and a portfolio of over 150 products. Stated priorities include customized formulation development, investments in product development infrastructure, quality assurance through certified manufacturing partners, and participation in medical education and public health awareness initiatives.
Industries
Nr. of Employees
large (251-1000)
Products
Amoxicillin 500 mg + Potassium clavulanate 125 mg + probiotic spores
Oral antibiotic combination formulation with added probiotic spores.
Cefixime 200 mg + Potassium clavulanate 125 mg
Oral cephalosporin antibiotic combination formulation.
Cefpodoxime 200 mg + Clavulanic acid 125 mg
Oral antibiotic combination formulation.
Cefuroxime axetil formulations (250 mg / 500 mg) with/without clavulanate
Oral cephalosporin formulations in single and combination forms.
Faropenem 200 mg and Faropenem 200 mg + Potassium clavulanate
Oral penem-class antibiotic formulations in monotherapy and combination forms.
Rifaximin oral formulations (400 mg / 550 mg)
Non-absorbable oral antibiotic formulations for gut-related indications.
Amoxicillin 500 mg + Potassium clavulanate 125 mg + probiotic spores
Oral antibiotic combination formulation with added probiotic spores.
Cefixime 200 mg + Potassium clavulanate 125 mg
Oral cephalosporin antibiotic combination formulation.
Cefpodoxime 200 mg + Clavulanic acid 125 mg
Oral antibiotic combination formulation.
Cefuroxime axetil formulations (250 mg / 500 mg) with/without clavulanate
Oral cephalosporin formulations in single and combination forms.
Faropenem 200 mg and Faropenem 200 mg + Potassium clavulanate
Oral penem-class antibiotic formulations in monotherapy and combination forms.
Rifaximin oral formulations (400 mg / 550 mg)
Non-absorbable oral antibiotic formulations for gut-related indications.
Services
Marketing and distribution of a portfolio of pharmaceutical formulations across multiple Indian states and channels including hospitals and medical practitioners.
Partnerships with certified manufacturing facilities for production of company formulations under cGMP/WHO-GMP and other quality systems.
Sponsorship and active participation in national and regional medical conferences and scientific initiatives to engage clinicians.
Marketing and distribution of a portfolio of pharmaceutical formulations across multiple Indian states and channels including hospitals and medical practitioners.
Partnerships with certified manufacturing facilities for production of company formulations under cGMP/WHO-GMP and other quality systems.
Sponsorship and active participation in national and regional medical conferences and scientific initiatives to engage clinicians.
Expertise Areas
- Pharmaceutical formulation development
- Customized combination formulations
- Antibiotics and anti-infective formulations
- Osteoporosis and osteoarthritis therapies
Key Technologies
- Pharmaceutical formulation development
- GMP manufacturing processes
- Analytical quality testing of APIs and finished products
- Laboratory accreditation and GLP-compliant testing
News & Updates
Held a record/recognition activity in 2022 focused on spreading diabetes awareness and supporting engagement with physicians and patients.
A scientific initiative run under the aegis of physician associations to discuss contemporary medical topics and decrypt clinical challenges.
Company-stated national ranking of specific product formulations within their respective market segments.
Held a record/recognition activity in 2022 focused on spreading diabetes awareness and supporting engagement with physicians and patients.
A scientific initiative run under the aegis of physician associations to discuss contemporary medical topics and decrypt clinical challenges.
Company-stated national ranking of specific product formulations within their respective market segments.